Proximagen
London, England, United Kingdom
About Proximagen
Proximagen is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $96.5M
- Last round: Series Unknown (Sep 2011)
- Website: proximagen.com
- Phone: 44 20 7400 7700
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/proximagen-2465003 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.